Abstract
Aim:
To demonstrate the hypothesis that dexamethasone (Dex) could improve chronic heart failure (CHF) by inhibiting the downstream signaling transduction of leptin but had no influence on the upregulation of leptin and its receptor in myocardium.
Methods:
CHF was induced by left coronary artery ligation for 6 weeks. CHF rats were treated with Dex 50 mg·kg−1·d−1. Hemodynamics, histology, reactive oxygen species (ROS)-related parameters, and leptin concentrations in serum were measured. The mRNA expression of matrix metalloproteinases (MMP) 2/9, tissue inhibitor of metalloproteinases (TIMP)1/2, tumor necrosis factor (TNF)-α, and OB-Rb were measured by RT-PCR.
Results:
In the CHF rats, hemodynamic functions were deteriorated, which was accompanied with myocardium remodeling and histological changes. CHF rats showed hyperleptinemia and excessive ROS in the serum, and the upregulation of MMP-2/9, TNF-α, and leptin receptor mRNA and downregulation of TIMP-1/2 mRNA in the myocardium compared with the sham operation group. Dex treatment significantly ameliorated CHF in association with the reversion of the abnormalities of MMP-2/9, TIMP-1/2, TNF-α, and ROS. But Dex had no influence on the hyperleptinemia and the upregulated leptin and its receptor in the myocardium during CHF.
Conclusion:
Dex improves CHF by inhibiting TNF-α, MMP-2, MMP-9, and ROS. Dex had no effects on upregulated leptin and its receptor expression and hyperleptinemia induced by CHF.
Similar content being viewed by others
Article PDF
References
Purdham DM, Zou MX, Rajapurohitam V, Karmazyn M . Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 2004; 287: H2877–84.
Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumle A, et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2006 May 17. [Epub ahead of print].
Piatti PC, Di Mario LD, Monti G, Fragasso F, Sgura A, Caumo A, et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003; 108: 2074–81.
Thakur V, Richards R, Reisin E . Obesity, hypertension, and the heart. Am J Med Sci 2001; 321: 242–8.
Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003; 5: 33–40.
Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J . Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004; 44: 1609–18.
Seddon M, Looi AYH, Shah M . Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2006; 2: [Epub ahead of print].
Castellucci MR, De Matteis A, Meisser R, Cancello V, Monsurro D, Islami, et al. Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod 2000; 6: 951–8.
Li L, Mamputu JC, Wiernsperger N, Renier G . Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes 2005; 54: 2227–34.
Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004; 110: 1269–75.
Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts CC, Vrints J . Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int J Cardiol 2006; 97: 970–3.
Finck BN, Johnson RW . Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1429–35.
Ishida-Takahashi R, Uotani S, Abe T, Degawa-Yamauchi M, Fukushima T, Fujita N, et al. Rapid inhibition of leptin signaling by glucocorticoids in vitro and in vivo. J Biol Chem 2004; 279: 19658–64.
Machuca C, Mendoza-Milla C, Cordova E, Mejia S, Covarrubias L, Ventura J, et al. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT. BMC Cell Biol 2006; 7: 9.
Bruder ED, Jacobson L, Raff H . Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia. J Endocrinol 2005; 185: 477–84.
Fried SK, Ricci MR, Russell CD, Laferrere B . Regulation of leptin production in humans. J Nutr 2000; 130: S3127–31.
Ren JD, Relling P . Interaction between tumor necrosis factor-alpha and leptin-induced inhibition of cardiac contractile function in isolated ventricular myocytes. Cytokine 2005; 32: 213–8.
Ren J . Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004; 181: 1–10.
Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430–5.
Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113: 2089–96.
Herpel E, Singer S, Flechtenmacher C, Pritsch M, Sack FU, Hagl S, et al. Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies. Virchows Arch 2005; 446: 369–78.
Wagner DR, Delagardelle C, Ernens I, Rouy D, Vaillant M, Beissel J . Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail 2006; 12: 66–72.
Matsusaka H, Ikeuchi M, Matsushima S, Ide T, Kubota T, Feldman AM, et al. Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 2005; 289: H1858–64.
Chancey AL, Brower GL, Peterson JT, Janicki JS . Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circulation 2002; 105: 1983–8.
Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, et al. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 2006; 98: 271–9.
Moe GW, Marin-Garcia J, Konig A, Goldenthal M, Lu X, Feng Q . In vivo TNF-inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 2004; 287: H1813–20.
Valen G, Kawakami T, Tahepold P, Dumitrescu A, Lowbeer C, Vaage J . Glucocorticoid pretreatment protects cardiac function and induces cardiac heart shock protein 72. Am J Physiol Heart Circ Physiol 2000; 279: H836–43.
Varga E, Nagy N, Lazar J, Czifra G, Bak I, Biro T, et al. Inhibition of ischemia/reperfusion-induced damage by dexamethasone in isolated working rat hearts: the role of cytochrome c release. Life Sci 2004; 75: 2411–23.
Ahima RS, Flier JS . Leptin. Annu Rev Physiol 2000; 62: 413–37.
Rajapurohitam V, Gan XT, Kirshenbaum M, Karmazyn LA . The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003; 93: 277–9.
Tosaki A, Koltai M, Joo F, Adam G, Szerdahelyi P, Lepran I, et al. Actinomycin D suppresses the protective effect of dexamethasone in rats affected by global cerebral ischemia. Stroke 1985; 16: 501–5.
Nishii N, Takasu M, Ohba Y, Maeda S, Kitoh K, Ohtsuka Y, et al. Effects of administration of glucocorticoids and feeding status on plasma leptin concentrations in dogs. Am J Vet Res 2006; 67: 266–70.
Luo JD, Zhang GS, Chen MS . Leptin and cardiovascular diseases. Drug News Perspect 2005; 18: 427–31.
Trujillo ME, Lee MJ, Sullivan S, Feng J, Schneider SH, Greenberg AS, et al. Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein. Clin Endocrinol Metab 2006; 91: 1484–90.
Ramsay TG, Richards MP . Hormonal regulation of leptin and leptin receptor expression in porcine subcutaneous adipose tissue. J Anim Sci 2004; 82: 3486–92.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Project supported by a grant from the Natural Science Foundation of Zhejiang Province (No Y204470) and a grant from the National Natural Science Foundation of China (No 30572193).
Rights and permissions
About this article
Cite this article
Xia, Qg., Na, T., Guo, Ym. et al. Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in rats. Acta Pharmacol Sin 28, 202–210 (2007). https://doi.org/10.1111/j.1745-7254.2007.00503.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00503.x
Keywords
This article is cited by
-
Cardiovascular effects of leptin
Nature Reviews Cardiology (2010)
-
Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCε in the heart, which are mitigated by endothelin receptor antagonist CPU0213
Acta Pharmacologica Sinica (2009)